thymosin beta-4 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-23. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Supplied as a lyophilised cake in sealed vials |
| Solubility class | Freely soluble in water | Polar and charged side chains dominate the sequence |
| Typical storage temperature | -20 °C or below | Dry and dark; a desiccant is often recommended |
| Identity confirmation | Mass spectrometry | Observed mass compared with the theoretical value |
| Common synonyms | Thymosin beta-4 fragment | Also written as T beta 4 fragment 17-23 |
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
==== Antivirals ==== Drugs that inhibit enzymes needed for the replication of viruses are effective in treating viral infections. Antiviral drugs include protease inhibitors used to treat HIV/AIDS and Hepatitis C, reverse-transcriptase inhibitors targeting HIV/AIDS, neuraminidase inhibitors targeting influenza, and terminase inhibitors targeting human cytomegalovirus.
Youths should not begin eating before their elders do. When eating from a bowl, one should not hold it with its bottom part, because it resembles the act of begging. Chopsticks are the main eating utensils for Chinese food, which can be used to cut and pick up food. When someone is taking a break from eating at the table, they should not put the chopstick into the rice vertically, because it resembles the Chinese traditional funeral tribute, which involves putting chopsticks inside a bowl of rice vertically. It is considered inappropriate to use knives on the dining table. Chopsticks should not be waved around in the air or played with. Food should first be taken from the plate in front. It is considered impolite to stare at a plate. Watching TV, using mobile phones or doing other activities while eating is considered in poor taste. If an older person puts food in a younger person's bowl, the younger person should thank them. Chinese culture has guidelines in how and when food are eaten. Chinese people typically eat three meals a day, consisting of breakfast, lunch, and dinner. Breakfast is served around 6–9am, lunch is served around 12–2pm, and dinner is served around 6–9pm. A late night, fourth meal of the day is known as siu yeh and served from 9pm-4am, which is similar to the Western concept of supper. Within the Chinese culture, families do follow different traditions. In some families, the elderly members and youngsters get their meal first, then the mother and father, and then the children and teenagers.
December 22: Ordinance on nursery schools (also called early childhood schools, for children under 6), establishing mixed-sex facilities. A man may direct such an institution, but a woman must always be assigned to it. A committee of "lady inspectors," family mothers appointed by the prefect, appoints directors and inspects and oversees these schools. 1838
==== National Strategy for Connected Schools ==== In September 2023, the government launched the National Strategy for Connected Schools (ENEC). The program is structured around four main connectivity pillars: deployment of high-speed internet access infrastructure; provision of adequate internet connectivity; installation of Wi-Fi networks in schools; and supply of electrical power. ENEC will receive investments of 8.8 billion reais, of which 6.5 billion reais come from the “Digital Inclusion and Connectivity” axis of the New PAC. Funding comes from four sources: the 5G auction, the Universal Service Fund for Telecommunications (Fust), the Connected Education Innovation Program (PIEC) and Law No. 14,172 of 2021.
Sources: en.wikipedia.org
In 1869, when Dmitri Mendeleev published his periodic table, the space under iodine was empty; after Niels Bohr established the physical basis of the classification of chemical elements, it was suggested that the fifth halogen belonged there. Before its officially recognized discovery, it was called "eka-iodine" (from Sanskrit eka 'one') to imply it was one space under iodine (in the same manner as eka-silicon, eka-boron, and others). Scientists tried to find it in nature; given its extreme rarity, these attempts resulted in several false discoveries. The first claimed discovery of eka-iodine was made by Fred Allison and his associates at the Alabama Polytechnic Institute (now Auburn University) in 1931. The discoverers named element 85 "alabamine", and assigned it the symbol Ab, designations that were used for a few years. In 1934, H. G. MacPherson of University of California, Berkeley disproved Allison's method and the validity of his discovery. There was another claim in 1937, by the chemist Rajendralal De. Working in Dacca in British India (now Dhaka in Bangladesh), he chose the name "dakin" for element 85, which he claimed to have isolated as the thorium series equivalent of radium F (polonium-210) in the radium series. The properties he reported for dakin do not correspond to those of astatine, and astatine's radioactivity would have prevented him from handling it in the quantities he claimed. Moreover, astatine is not found in the thorium series, and the true identity of dakin is not known.
The endocrine function of gonadotrophs is derived from the effect of gonadotropins on the reproductive system. The gonadotropins produced by gonadotropic cells are FSH and LH, which are dimeric pituitary glycoprotein hormones with a common alpha subunit and distinct beta subunit that confers biological activity of the hormones. These hormones are synthesized in the ER of gonadotropic cells and then passed through the Golgi apparatus. After modification and packaging within the Golgi complex, the hormones are delivered to the plasma membrane through constitutive or regulated secretory pathways. The regulated pathway involves the fusion of the secretory vesicles containing FSH and LH to the gonadotroph membrane, and the vesicle is arrested waiting for specific signals, such as increased calcium levels from electrical activity and signaling pathways, that activate secretion of the hormones. The gonadotropins FSH and LH regulate the development of follicles, also known as folliculogenesis, in females, and the development of sperm in males. More specifically, the released FSH acts on ovarian granulosa and testicular Sertoli cells, while LH acts on ovarian theca and testicular Leydig cells. The release of these hormones are directly signaled by the pulsing secretion of GnRH. For example, the low frequency GnRH pulses lead to the release of FSH and the high-frequency of GnRH pulses lead to the release of LH. Therefore, the controlled release of FSH and LH from gonadotrophs allows for precise control of gonadal function.
Hahn was shot in the back in October 1951 by a disgruntled inventor who wished to highlight the neglect of his ideas by mainstream scientists. Hahn was injured in a motor vehicle accident in 1952, and had a minor heart attack the following year. In 1962, he published a book, Vom Radiothor zur Uranspaltung (lit. 'From Radiothorium to Uranium Fission'). It was released in English in 1966 with the title Otto Hahn: A Scientific Autobiography, with an introduction by Glenn Seaborg. The success of this book may have prompted him to write another, fuller autobiography, Otto Hahn. Mein Leben, but before it could be published, he fractured one of the vertebrae in his neck while getting out of a car. He gradually became weaker and died in Göttingen on 28 July 1968. His wife Edith survived him by only a fortnight. He was buried in the Stadtfriedhof in Göttingen. The day after his death, the Max Planck Society published the following obituary notice:
HA and HA fragment-tumor cell interaction could activate the downstream signaling pathways, promoting cell proliferation, adhesion, migration and invasion, and inducing angiogenesis, lymphangiogenesis, epithelial-mesenchymal transition, stem cell-like property, and chemoradioresistance in digestive cancers.
The mechanism of SDA is unknown, but in the case of dietary carbohydrates, it has been shown to be strongly related to increases in sympathetic activity. TEF has been described as the energy used in the distribution of nutrients and metabolic processes in the liver. For example, dietary protein produces a high TEF because of the high energy costs associated with processing it, and it has been shown that hepatectomized animal exhibits no signs of TEF. By contrast, the energy costs of the digestion and absorption of food play a much less significant role; indeed, research shows that intravenous injections of nutrients such as glucose or amino acids results in an effect equal to that of oral ingestion of the same nutrients.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.
It corresponds to the actin-binding region of thymosin beta-4. Commercial synthesis reproduces that seven-residue stretch, usually with an acetyl group on the N-terminus.
It is not authorised as a medicine in the United States or the European Union and is distributed as a research chemical. Labels consequently carry research-use-only statements rather than clinical indications.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.